Brian Durie, MD, Cedars-Sinai Samuel Oschin Cancer Center, Los Angeles, CA, discusses disparities in myeloma care, with a particular focus on access inequalities to treatment. He mentions a program in the US that is underway to improve access to standard-of-care (SoC) therapies and novel immunotherapies for African American patients. This interview took place at The 10th World Congress on Controversies in Multiple Myeloma (COMy) in Paris, France.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.